Lidocain-Hcl B. Braun

Lidocaine, the active ingredient in Lidocain-Hcl B. Braun, is a local anesthetic presented as a sterile solution for epidural, infiltration, intradermal and subcutaneous use. It provides reversible nerve block to facilitate analgesia and minor surgical procedures in adult patients. GNH USA supplies Lidocain-Hcl B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lidocaine is a local anesthetic used in several procedural pathways to achieve temporary loss of sensation. - Epidural analgesia: provides pain relief during labor or postoperative periods by blocking spinal nerve transmission. - Infiltration anesthesia for minor surgical procedures: numbs targeted tissue to allow minor incisions without systemic analgesia. - Intradermal skin testing: creates a localized, short‑lasting numb area for allergy or diagnostic skin tests. - Subcutaneous local anesthesia: facilitates minor injections or suturing by anesthetizing the subdermal layer.

Lidocaine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging at the injection site - Mild dizziness or light‑headedness - Transient visual disturbances - Nausea or mild gastrointestinal upset - Localized swelling or erythema

Serious or Rare Side Effects: - Cardiovascular depression or arrhythmias - Central nervous system toxicity (e.g., seizures, loss of consciousness) - Severe allergic reactions (anaphylaxis, angioedema) - Methemoglobinemia - Persistent numbness beyond the expected duration

When using lidocaine, clinicians should observe several safety measures. - Patient assessment: evaluate cardiac history and allergy status before administration. - Dosage limits: adhere to recommended maximum doses to avoid systemic toxicity. - Monitoring: observe for signs of CNS or cardiovascular effects during and after injection. - Drug interactions: review concomitant medications that may potentiate lidocaine toxicity. - Special populations: use caution in pediatric, geriatric, or hepatic‑impaired patients. Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Lidocaine can interact with other agents that affect cardiac conduction or metabolism.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): additive cardiac depressant effects. - Beta‑blockers: may enhance bradycardia and hypotension. - CYP3A4 inhibitors (e.g., ketoconazole): increase systemic lidocaine levels.

Moderate Interactions (Monitor Closely): - Other local anesthetics: risk of cumulative toxicity. - Diuretics (e.g., furosemide): may potentiate hypotensive response. - Anticonvulsants: may lower seizure threshold when lidocaine levels rise.